title: Stimulation of dog RVLM and A5 area changes sympathetic outflow to vascular beds without effect on the heart.
abstract: Studies were conducted in anesthetized, vagotomized dogs while blood pressure; blood flows in femoral, renal, mesenteric, and left circumflex coronary arteries; electrocardiogram; and regional cardiac contractile force were monitored. The ventral surface of the medulla was exposed, and pressor sites in the rostral ventrolateral medulla (RVLM) were mapped by microinjections of L-glutamate. L-Glutamate activation of the RVLM evoked selective effects on different components of the cardiovascular system. Increases of 20-130 mmHg in blood pressure were accompanied by vascular conductance decreases in the femoral (-48 +/- 4%), renal (-30 +/- 4%), and mesenteric (-38 +/- 3%) arterial beds. These effects were without any obvious topography within the RVLM. There were only small or negligible changes in heart rate (HR), cardiac contractile force, and coronary vascular conductance. Thus stimulation of the canine RVLM increased sympathetic tone selectively to structures other than the heart. Stimulation of the ventral medulla in a region that lay rostral to the RVLM and ventromedial to the facial nucleus selectively increased femoral vascular conductance by 103 +/- 33% and decreased vascular conductance in the renal (-20 +/- 5%) and mesenteric (-15 +/- 4%) arterial beds. There was no increase in HR, and the increases in blood pressure were relatively small. Immunohistochemical data led us, tentatively, to identify this rostral area as overlapping part of the A5 area.
authors.affiliation: Department of Pharmacology, Georgetown University, Washington, District of Columbia 20007, USA.
authors.forename: L W
authors.initials: LW
authors.lastname: Dickerson
authors.forename: W H
authors.initials: WH
authors.lastname: Panico
authors.forename: F E
authors.initials: FE
authors.lastname: Kuhn
authors.forename: A C
authors.initials: AC
authors.lastname: Willis
authors.forename: J F
authors.initials: JF
authors.lastname: Fitzgerald
authors.forename: E L
authors.initials: EL
authors.lastname: Meyer
authors.forename: W P
authors.initials: WP
authors.lastname: Norman
authors.forename: R A
authors.initials: RA
authors.lastname: Gillis
mesh_terms: D000818:Animals; D001794:Blood Pressure; D001931:Brain Mapping; D003326:Coronary Circulation; D003971:Diastole; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D005263:Femoral Artery / Q000502:physiology; D018698:Glutamic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006339:Heart Rate; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects / Q000502:physiology*; D008638:Mesenteric Arteries / Q000502:physiology; D008845:Microinjections; D009200:Myocardial Contraction; D009474:Neurons / Q000502:physiology*; D012039:Regional Blood Flow / Q000187:drug effects; D012077:Renal Artery / Q000502:physiology; D013599:Systole; D014628:Vagotomy; D016277:Ventricular Function, Left
chemical_list: D018698:Glutamic Acid